ROIV News and Press, Roivant Sciences Ltd.

2026-03-04 23:42:41 ET According to a recent SEC filing dated February 17, 2026, BlackBarn Capital Partners LP bought an additional two million shares of Warby Parker (NYSE:WRBY) , bringing its total position to three million shares. The estimated transaction value was $43.52 millio...

2026-03-04 11:05:30 ET Thesis As you now know, Moderna, Inc.’s ( MRNA ) settlement with Arbutus Biopharma ( ABUS ) and Genevant Science ( ROIV ) is going to require a pretty hefty upfront payment of $950 million. However, as I will explain, I think this ou...

2026-03-04 09:18:05 ET More on Moderna, Arbutus Biopharma, etc. Roivant Sciences Ltd. (ROIV) Discusses $2.25 Billion Global Settlement Resolving COVID Vaccine Patent Litigation Transcript Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript...

2026-03-04 05:22:18 ET Roivant Sciences Ltd. (ROIV) Discusses $2.25 Billion Global Settlement Resolving COVID Vaccine Patent Litigation March 3, 2026 4:45 PM EST... Read the full article on Seeking Alpha For further details see: Roivant Sciences Ltd. (ROIV) Discusses $2.25 B...

2026-03-03 17:16:52 ET More on Moderna Moderna, Inc. (MRNA) Presents at TD Cowen 46th Annual Health Care Conference Transcript Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation EMA recommends au...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is realized, this settlement will be the largest disclosed patent settlement paid in the pharmaceutic...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is realized, this settlement will be the largest disclosed patent settlement paid in the pharmaceutic...

2026-03-03 13:32:12 ET Roivant Sciences Ltd. (ROIV) TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM EST... Read the full article on Seeking Alpha For further details see: Roivant Sciences Ltd. (ROIV) Presents at TD Cowen 46th Annual Health Care Conference T...

2026-03-03 07:24:49 ET More on Pfizer, Roivant Sciences Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer...

FDA assigns PDUFA target action date in the third quarter of calendar year 2026 with launch expected at the end of September 2026 Priority Review supported by positive Phase 3 VALOR results, the first positive 52-week placebo-controlled trial in dermatomyositis If approved, brepocitinib would r...